Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,054

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

GISAID’s Role in Pandemic Response

Open access
Khare, Shruti, GISAID Global Data Science Initiative (GISAID), Munich, Germany, Gurry, Céline, Freitas, Lucas, B Schultz, Mark, Bach, Gunter, Diallo, Amadou, Akite, Nancy, Ho, Joses, TC Lee, Raphael, Yeo, Winston, Core Curation Team, GISAID, Maurer-Stroh, Sebastian, Bioinformatics Institute, Agency for Science Technology and Research, Singapore, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil, Institut Pasteur de Dakar, Dakar, Senegal, National Institutes of Biotechnology Malaysia, Selangor, Malaysia, Smorodintsev Research Institute of Influenza, St. Petersburg, Russia, Genome Institute of Singapore, Agency for Science Technology and Research, Singapore, China National GeneBank, Shenzhen, China, A*STAR Infectious Disease Labs (ID Labs), Singapore, National Public Health Laboratory, National Centre for Infectious Diseases, Ministry of Health, Singapore, Department of Biological Sciences, National University of Singapore, Singapore·2021·China CDC Weekly

Abstract

GISAID is a global data science initiative and the primary source of genomic and associated metadata of all influenza viruses, Respiratory Syncytial Virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic coronavirus causing coronavirus disease 2019 (COVID-19).GISAID's publicly accessible data sharing platform enables collaboration of over 42,000 participating researchers from 198 nations and data generators from over 3,500 institutions across the globe.Since the first wholegenome sequences were made available by China CDC through GISAID on January 10, 2020, over 5 million genetic sequences of SARS-CoV-2 from 194 countries and territories have been made publicly available through GISAID's EpiCoV database as of November 9, 2021.This high-quality, curated data enabled the rapid development of diagnostic and prophylactic measures against SARS-CoV-2 including the first diagnostic tests and the first vaccines to combat COVID-19 as well as continuous monitoring of emerging variants in near real-time.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.46234/ccdcw2021.255

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 1,054

Metadata

Authors
Khare, S., GISAID Global Data Science Initiative (GISAID), M., Gurry, C., Freitas, L., B Schultz, M., Bach, G., Diallo, A., Akite, N., Ho, J., TC Lee, R., Yeo, W., Core Curation Team, G., Maurer-Stroh, S., Bioinformatics Institute, A. F. S. T. A. R., Oswaldo Cruz Foundation (FIOCRUZ), R. D. J., Institut Pasteur de Dakar, D., National Institutes of Biotechnology Malaysia, S., Smorodintsev Research Institute of Influenza, S. P., Genome Institute of Singapore, A. F. S. T. A. R., China National GeneBank, S., A*STAR Infectious Disease Labs (ID Labs), S., National Public Health Laboratory, N. C. F. I. D., & Department of Biological Sciences, N. U. O. S.
Venue
China CDC Weekly
Published
2021
Volume
3
Issue
49
Pages
1049-1051
ISSN
2096-7071 (ISSN-L)
OpenAlex
W4200137031
Cited by
1,054
References
5
FWCI
59.15
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GISAID’s Role in Pandemic Response. https://app.cochat.ai/papers/10.46234/ccdcw2021.255
The paper
Khare, S., GISAID Global Data Science Initiative (GISAID), M., Gurry, C., Freitas, L., B Schultz, M., Bach, G., Diallo, A., Akite, N., Ho, J., TC Lee, R., Yeo, W., Core Curation Team, G., Maurer-Stroh, S., Bioinformatics Institute, A. F. S. T. A. R., Oswaldo Cruz Foundation (FIOCRUZ), R. D. J., Institut Pasteur de Dakar, D., National Institutes of Biotechnology Malaysia, S., Smorodintsev Research Institute of Influenza, S. P., Genome Institute of Singapore, A. F. S. T. A. R., . . . Department of Biological Sciences, N. U. O. S. (2021). GISAID’s Role in Pandemic Response. China CDC Weekly. https://doi.org/10.46234/ccdcw2021.255

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.